Heart Protection by Combination Therapy with Esmolol and Milrinone at Late-Ischemia and Early Reperfusion

INTRODUCTION: The present study determined whether late-ischemia/early reperfusion therapy with the β(1)-adrenergic receptor (AR) blocker esmolol and phosphodiesterase III inhibitor milrinone reduced left ventricular (LV) myocardial infarct size (IS). METHODS AND RESULTS: In an ischemia/reperfusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ming-He, Wu, Yewen, Nguyen, Vincent, Rastogi, Saurabh, McConnell, Bradley K., Wijaya, Cori, Uretsky, Barry F., Poh, Kian-Keong, Tan, Huay-Cheem, Fujise, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110274/
https://www.ncbi.nlm.nih.gov/pubmed/21562974
http://dx.doi.org/10.1007/s10557-011-6302-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110274/
https://www.ncbi.nlm.nih.gov/pubmed/21562974
http://dx.doi.org/10.1007/s10557-011-6302-z

Ejemplares similares